IMMUCELL CORP /DE/ - COM PAR (ICCC)

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class
Equity / COM PAR
Number of holders
26
Total 13F shares, excl. options
784,556
Shares change
+37,797
Total reported value, excl. options
$7,452,000
Value change
+$356,265
Number of buys
5
Number of sells
-7
Price
$9.5

Significant Holders of IMMUCELL CORP /DE/ - COM PAR (ICCC) as of Q2 2021

27 filings reported holding ICCC - IMMUCELL CORP /DE/ - COM PAR as of Q2 2021.
IMMUCELL CORP /DE/ - COM PAR (ICCC) has 26 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 784,556 shares .
Largest 10 shareholders include RENAISSANCE TECHNOLOGIES LLC (178,156 shares), VANGUARD GROUP INC (147,236 shares), OVERBROOK MANAGEMENT CORP (87,225 shares), Bleichroeder LP (60,607 shares), MORGAN STANLEY (55,874 shares), PERRITT CAPITAL MANAGEMENT INC (50,000 shares), Strategic Financial Services, Inc, (30,028 shares), GEODE CAPITAL MANAGEMENT, LLC (20,434 shares), DIMENSIONAL FUND ADVISORS LP (19,408 shares), and SHUFRO ROSE & CO LLC (17,909 shares).
This table shows the top 26 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.